Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions

Journal of Korean Medical Science

Volumn 22, Issue 1, 2007, Pages 99-104

  Song, Eun Seop ^a   Hun, Jae Lee ^a   Tae, Sook Hwang ^b  

^a Inha University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Cervical swab; DNA probes, HPV; Microarray analysis; Oligonucleotide microarray; Urine; Vaginal smears

Indexed keywords

EID: 33847100966     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.1.99     Document Type: Article

References (26)

1. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with HPV DNA Chip microarray method. Cancer 2003; 97: 1672-80.
2. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
3. Lee HP, Seo SS. The application of human papillomavirus testing to cervical cancer screening. Yonsei Med J 2002; 43: 763-8.
4. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
5. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996; 68: 766-9.
6. Stanley MA. Human papillomavirus vaccines. Rev Med Virol 2006; 16: 139-49.
7. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994; 186: 1-12.
8. Ackermann SP, Brackbill RM, Bewerse BA, Cheal NE, Sanderson LM. Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989. MMWR CDC Surveill Summ 1992; 41: 17-25.
9. Anderson, LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995; 85: 840-2.
10. Breeze C, de Costa , Jagusch M. Do women in rural and remote areas need different guidelines for management of low-grade abnormalities found on cervical screening? Med J Aust 2006; 184: 307-8.
11. KMOHW (Korean Ministry of Health and Welfare). A study on the expansion of national cancer screening programme. 2004.
12. Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis 2004; 1: 1-15.
13. Reddy DM, Wasserman SA. Patient anxiety during gynecologic examinations. Behavioral indicators. J Reprod Med 1997; 42: 631-6.
14. Prusty BK, Kumar A, Arora R, Batra S, Das BC. Human papillomavirus (HPV) DNA detection in self-collected urine. Int Gynecol Obstet 2005; 90: 223-7.
15. Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli K, Maehr J, Daniel RW, Shah KV. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 2000; 19: 722-8.
16. Vossler JL, Forbes BA, Adelson MD. Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J Med Virol 1995; 45: 354-60.
17. Song ES, Koh SH, Song YS, Kim SR, Hwang SO, Park JH, Koh SK, Im MW, Lee BI, Lee WY. The report of the results of HPV oligonucleotide microarray tested on the first voided urine of patients of CIN and cervix cancer. Korean J Obstet gynecol 2003; 46: 2139-45.
18. Hwang TS, Jeong JK, Park M, Han HS, Choi HK, Park TS. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003; 90: 51-6.
19. Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol 1987; 126: 161-9.
20. KMOHW (Korean Ministry of Health and Welfare). Overview of Cancer Control Programs in Korea. 2004.
21. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-6.
22. Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997; 35: 1536-40.
23. Stanczuk GA, Kay P, Allan B, Chirara M, Tswana SA, Bergstrom S, Sibanda EN, Williamson AL. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer. J Med Virol 2003; 71: 110-4.
24. Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chatuvedi AK, Slavinsky III J, Clayton JL, Dumestre J, Hagensee ME. Dectection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol 2002; 40: 3155-61.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
26. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141: 680-9.